NPI: 1366459570 · MANHASSET, NY 11030 · Ambulance · NPI assigned 08/01/2006
Authorized official CUSACK, MICHELE controls 20+ related entities in our dataset. Read more
| Authorized Official | CUSACK, MICHELE (SENIOR VICE PRESIDENT & CFO) |
| NPI Enumeration Date | 08/01/2006 |
Other providers sharing the same authorized official: CUSACK, MICHELE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,262 | $1.03M |
| 2019 | 70,539 | $5.43M |
| 2020 | 168,244 | $13.10M |
| 2021 | 242,791 | $18.08M |
| 2022 | 255,648 | $17.12M |
| 2023 | 256,885 | $18.43M |
| 2024 | 200,918 | $14.49M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 33,081 | 29,266 | $4.34M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 23,116 | 22,200 | $3.92M |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 36,569 | 32,497 | $3.86M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 12,377 | 12,200 | $3.41M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21,072 | 20,388 | $2.95M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21,979 | 18,118 | $2.72M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 5,077 | 4,997 | $2.63M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 13,665 | 13,339 | $2.59M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12,888 | 12,508 | $2.24M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,131 | 1,121 | $2.11M |
| C1889 | Implantable/insertable device, not otherwise classified | 20,938 | 3,729 | $2.11M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 16,453 | 16,255 | $1.96M |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1,710 | 1,664 | $1.87M |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 21,265 | 20,926 | $1.67M |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 4,118 | 3,893 | $1.53M |
| G0378 | Hospital observation service, per hour | 2,335 | 1,728 | $1.49M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 3,865 | 3,782 | $1.46M |
| 76641 | 12,047 | 10,865 | $1.38M | |
| 19083 | 1,093 | 1,049 | $1.30M | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 3,530 | 3,502 | $1.27M |
| 72197 | 2,673 | 2,602 | $1.25M | |
| 93975 | 2,927 | 2,844 | $1.19M | |
| 74183 | 2,463 | 2,425 | $1.12M | |
| A9585 | Injection, gadobutrol, 0.1 ml | 12,735 | 12,461 | $1.06M |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 6,777 | 6,687 | $928K |
| 70450 | Computed tomography, head or brain; without contrast material | 5,893 | 5,765 | $899K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1,123 | 1,097 | $888K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 5,038 | 4,967 | $873K |
| 52000 | 941 | 931 | $867K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 12,248 | 11,605 | $837K |
| 72141 | 2,260 | 2,243 | $767K | |
| 76830 | Ultrasound, transvaginal | 6,449 | 6,376 | $765K |
| 71250 | 5,074 | 5,010 | $712K | |
| 80053 | Comprehensive metabolic panel | 39,524 | 37,147 | $675K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 2,052 | 2,041 | $670K |
| 77049 | 1,387 | 1,288 | $670K | |
| 73221 | 2,011 | 1,946 | $642K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,127 | 3,064 | $629K |
| 76536 | 5,475 | 5,424 | $604K | |
| A0434 | Specialty care transport (sct) | 2,334 | 2,202 | $597K |
| A0425 | Ground mileage, per statute mile | 72,599 | 62,623 | $587K |
| 74178 | 1,489 | 1,466 | $576K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,045 | 3,011 | $576K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,948 | 2,871 | $562K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 4,355 | 4,332 | $538K |
| 93454 | 304 | 292 | $505K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,006 | 1,004 | $467K |
| 93970 | 1,754 | 1,732 | $462K | |
| A4648 | Tissue marker, implantable, any type, each | 1,769 | 1,723 | $447K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 16,444 | 16,246 | $440K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,038 | 2,003 | $439K |
| 77066 | Tomosynthesis, mammo | 3,041 | 2,999 | $413K |
| C1769 | Guide wire | 3,012 | 2,925 | $404K |
| 76770 | 2,493 | 2,454 | $391K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,142 | 2,068 | $367K |
| 77065 | Tomosynthesis, mammo | 3,710 | 3,390 | $361K |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 1,868 | 1,816 | $360K |
| 75574 | 1,442 | 1,419 | $360K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,923 | 3,182 | $358K |
| 95806 | 600 | 583 | $356K | |
| 86850 | 13,956 | 12,201 | $355K | |
| 93458 | 177 | 172 | $345K | |
| 70491 | 1,681 | 1,640 | $342K | |
| 76642 | 4,128 | 4,014 | $341K | |
| 71046 | Radiologic examination, chest; 2 views | 11,375 | 11,140 | $282K |
| 95782 | 285 | 276 | $272K | |
| 70486 | 1,911 | 1,895 | $270K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,201 | 2,179 | $269K |
| 59025 | Fetal non-stress test | 1,466 | 1,267 | $263K |
| 76775 | 3,560 | 3,518 | $246K | |
| 77080 | 3,409 | 3,373 | $234K | |
| 10005 | 635 | 625 | $232K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1,776 | 1,757 | $231K |
| 86901 | 13,619 | 11,839 | $228K | |
| 70498 | 1,243 | 1,232 | $220K | |
| 62323 | 473 | 444 | $213K | |
| 86900 | 14,120 | 12,312 | $209K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 302 | 302 | $206K |
| 70544 | 841 | 828 | $200K | |
| 93971 | 1,770 | 1,749 | $196K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 521 | 407 | $196K |
| 80048 | Basic metabolic panel (calcium, ionized) | 11,763 | 10,864 | $196K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 3,026 | 2,981 | $183K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 9,642 | 9,275 | $177K |
| D0120 | Periodic oral evaluation - established patient | 3,438 | 2,003 | $175K |
| 73700 | 1,109 | 1,061 | $171K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 4,564 | 4,504 | $170K |
| 77085 | 785 | 771 | $165K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 2,598 | 2,407 | $162K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,237 | 1,227 | $161K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 12,974 | 12,504 | $160K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 8,702 | 8,379 | $155K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6,292 | 6,239 | $154K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 2,344 | 2,265 | $153K |
| 71271 | 1,385 | 1,374 | $152K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 947 | 941 | $150K |
| 86923 | 1,171 | 844 | $146K | |
| 36415 | Collection of venous blood by venipuncture | 25,820 | 23,773 | $143K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 986 | 980 | $142K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5,043 | 4,912 | $141K |
| 51700 | 516 | 332 | $141K | |
| 72146 | 467 | 461 | $138K | |
| 70496 | 1,372 | 1,360 | $136K | |
| 99215 | Prolong outpt/office vis | 807 | 798 | $128K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 105 | 88 | $122K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 941 | 939 | $117K |
| 86922 | 1,138 | 786 | $114K | |
| 76000 | 1,560 | 1,535 | $109K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6,308 | 6,259 | $107K |
| 95800 | 561 | 515 | $106K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,718 | 5,481 | $106K |
| 82803 | 7,570 | 7,256 | $104K | |
| 76942 | 792 | 777 | $96K | |
| 86480 | 1,640 | 1,628 | $96K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,112 | 962 | $95K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,406 | 1,329 | $95K |
| 95811 | 131 | 127 | $93K | |
| 78816 | 92 | 89 | $91K | |
| J3490 | Unclassified drugs | 14,039 | 12,872 | $85K |
| D1110 | Prophylaxis - adult | 1,636 | 1,355 | $84K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,904 | 2,655 | $83K |
| 93356 | 351 | 349 | $79K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 7,510 | 7,141 | $78K |
| C9399 | Unclassified drugs or biologicals | 1,793 | 1,777 | $75K |
| 86902 | 144 | 100 | $74K | |
| 76870 | 865 | 846 | $73K | |
| 74174 | 231 | 231 | $72K | |
| C8937 | Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure) | 1,144 | 1,136 | $72K |
| 72156 | 200 | 197 | $69K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2,962 | 2,950 | $67K |
| 73130 | 1,933 | 1,814 | $64K | |
| 87536 | 1,429 | 1,407 | $63K | |
| 97161 | 807 | 795 | $63K | |
| 90715 | 2,299 | 2,286 | $62K | |
| 51797 | 237 | 229 | $62K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,339 | 1,311 | $61K |
| C9290 | Injection, bupivacaine liposome, 1 mg | 250 | 250 | $60K |
| 72100 | 1,684 | 1,674 | $59K | |
| 73718 | 169 | 153 | $57K | |
| 88185 | 239 | 223 | $57K | |
| 73030 | 1,940 | 1,874 | $55K | |
| 72110 | 1,018 | 1,005 | $55K | |
| 87641 | 1,907 | 1,893 | $49K | |
| 73630 | 2,062 | 1,941 | $48K | |
| 83880 | 2,664 | 2,613 | $47K | |
| D0140 | Limited oral evaluation - problem focused | 1,320 | 1,004 | $46K |
| 72157 | 115 | 109 | $46K | |
| 86360 | 1,218 | 1,208 | $46K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,801 | 2,503 | $46K |
| 90834 | Psychotherapy, 45 minutes with patient | 318 | 274 | $44K |
| 73562 | 1,603 | 1,537 | $43K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 174 | 170 | $42K |
| 93880 | 170 | 169 | $42K | |
| 76882 | 1,070 | 1,019 | $41K | |
| 88321 | 269 | 265 | $41K | |
| 72158 | 113 | 109 | $40K | |
| 75561 | 49 | 49 | $39K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3,881 | 3,791 | $38K |
| 77072 | 1,160 | 1,142 | $38K | |
| 88271 | 179 | 119 | $38K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 472 | 420 | $38K |
| 0225U | 3,467 | 3,392 | $38K | |
| 76377 | 1,286 | 1,243 | $38K | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | 551 | 527 | $37K |
| 93017 | 616 | 614 | $37K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,915 | 1,881 | $37K |
| 93308 | 287 | 259 | $35K | |
| 85027 | 23,518 | 22,162 | $34K | |
| 78306 | 146 | 145 | $34K | |
| 80061 | Lipid panel | 3,553 | 3,499 | $33K |
| 72131 | 309 | 300 | $33K | |
| 88307 | 546 | 514 | $33K | |
| 70480 | 191 | 190 | $33K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 11,043 | 10,476 | $33K |
| 70543 | 77 | 76 | $32K | |
| 74018 | 1,060 | 1,022 | $32K | |
| 76376 | 905 | 840 | $32K | |
| 64483 | 56 | 54 | $31K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 261 | 260 | $31K |
| 83020 | 1,326 | 1,102 | $31K | |
| 73110 | 1,103 | 1,060 | $31K | |
| J2704 | Injection, propofol, 10 mg | 7,824 | 7,705 | $30K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 17,164 | 16,053 | $30K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 14 | 13 | $29K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3,267 | 3,246 | $29K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1,037 | 1,035 | $29K |
| 71045 | Radiologic examination, chest; single view | 6,636 | 6,463 | $28K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 192 | 192 | $28K |
| 73610 | 1,472 | 1,413 | $28K | |
| 88237 | 155 | 98 | $27K | |
| 85610 | 10,043 | 9,284 | $27K | |
| D7140 | Extraction, erupted tooth or exposed root | 309 | 218 | $27K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 39 | 39 | $26K |
| 88304 | 1,118 | 1,098 | $26K | |
| 19281 | 25 | 25 | $26K | |
| 76937 | 221 | 210 | $25K | |
| 76818 | 300 | 174 | $25K | |
| G0008 | Administration of influenza virus vaccine | 1,640 | 1,637 | $24K |
| 90651 | 92 | 92 | $24K | |
| 96376 | 1,768 | 1,580 | $24K | |
| 73564 | 793 | 762 | $24K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 829 | 478 | $22K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3,383 | 3,265 | $22K |
| 86359 | 1,169 | 1,160 | $22K | |
| 72040 | 649 | 647 | $22K | |
| 19081 | 13 | 13 | $21K | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | 104 | 104 | $20K |
| 88173 | 716 | 684 | $20K | |
| 99386 | 156 | 156 | $20K | |
| 36000 | 886 | 867 | $20K | |
| 90688 | 1,063 | 1,061 | $19K | |
| C1760 | Closure device, vascular (implantable/insertable) | 53 | 53 | $19K |
| 73502 | 708 | 701 | $19K | |
| 87800 | 928 | 920 | $19K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 980 | 972 | $18K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 741 | 736 | $18K |
| 87653 | 578 | 575 | $17K | |
| 81025 | 6,670 | 6,558 | $17K | |
| 86769 | 784 | 778 | $17K | |
| 88275 | 175 | 116 | $17K | |
| 82565 | 2,498 | 2,482 | $16K | |
| 88172 | 323 | 316 | $15K | |
| 86780 | 3,774 | 3,742 | $15K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 5,159 | 4,970 | $15K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 84 | 82 | $14K |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 117 | 111 | $14K |
| 36224 | 27 | 26 | $14K | |
| 76498 | 318 | 276 | $14K | |
| 84702 | 7,612 | 7,089 | $14K | |
| D0274 | Bitewings - four radiographic images | 369 | 237 | $13K |
| 51784 | 170 | 165 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 10,877 | 10,419 | $13K |
| C1874 | Stent, coated/covered, with delivery system | 12 | 12 | $13K |
| 99385 | 105 | 105 | $13K | |
| 81003 | 9,441 | 7,337 | $12K | |
| 84443 | Thyroid stimulating hormone (TSH) | 4,491 | 4,434 | $12K |
| 72070 | 298 | 297 | $11K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 22,541 | 21,204 | $11K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 123 | 96 | $11K |
| 83036 | Hemoglobin; glycosylated (A1C) | 7,092 | 7,047 | $11K |
| 74160 | 63 | 63 | $11K | |
| 12001 | 27 | 27 | $11K | |
| 86703 | 1,083 | 1,069 | $10K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 7,094 | 6,988 | $10K |
| 20611 | 15 | 15 | $10K | |
| 55700 | 12 | 12 | $10K | |
| 78830 | 27 | 27 | $9K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,789 | 3,563 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 6,541 | 6,233 | $9K |
| 87631 | 251 | 249 | $9K | |
| 86803 | 1,778 | 1,772 | $9K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 41 | 41 | $9K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 9,983 | 9,625 | $9K |
| 49083 | 18 | 13 | $9K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 14 | 14 | $9K |
| 86353 | 199 | 198 | $9K | |
| A0433 | Advanced life support, level 2 (als 2) | 59 | 56 | $9K |
| C9600 | Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch | 12 | 12 | $9K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 50 | 50 | $8K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 52 | 52 | $8K |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,100 | 2,014 | $8K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,938 | 1,804 | $8K |
| D0150 | Comprehensive oral evaluation - new or established patient | 180 | 148 | $8K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 25 | 25 | $8K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 638 | 610 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,755 | 1,543 | $8K |
| 81513 | 133 | 132 | $7K | |
| A9561 | Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries | 134 | 134 | $7K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 6,878 | 6,759 | $7K |
| D0220 | Intraoral - periapical first radiographic image | 484 | 447 | $7K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 156 | 155 | $7K |
| 83690 | 7,903 | 7,634 | $7K | |
| 82330 | 6,281 | 6,000 | $7K | |
| 90732 | 127 | 126 | $7K | |
| 88184 | 202 | 194 | $6K | |
| 77001 | 28 | 27 | $6K | |
| 83655 | 482 | 479 | $6K | |
| 82962 | 6,640 | 5,817 | $6K | |
| 99205 | Prolong outpt/office vis | 39 | 39 | $6K |
| 88312 | 193 | 192 | $6K | |
| 87340 | 1,814 | 1,808 | $6K | |
| 90656 | 374 | 373 | $6K | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,848 | 1,509 | $6K |
| 72195 | 12 | 12 | $6K | |
| D0330 | Panoramic radiographic image | 157 | 147 | $6K |
| 73120 | 120 | 100 | $5K | |
| 12011 | 13 | 13 | $5K | |
| 87481 | 133 | 132 | $5K | |
| 85730 | 8,125 | 7,865 | $5K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 5,244 | 5,066 | $5K |
| 86762 | 577 | 574 | $5K | |
| Q3014 | Telehealth originating site facility fee | 209 | 203 | $5K |
| 88341 | 179 | 176 | $5K | |
| 86765 | 618 | 616 | $5K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 67 | 52 | $5K |
| 87640 | 1,800 | 1,783 | $5K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,781 | 3,686 | $5K |
| 86481 | 116 | 115 | $5K | |
| 73590 | 367 | 357 | $5K | |
| 81001 | 11,760 | 11,325 | $4K | |
| 76801 | 53 | 50 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 333 | 330 | $4K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,431 | 3,400 | $4K |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 1,182 | 1,165 | $4K |
| C1758 | Catheter, ureteral | 89 | 87 | $4K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 163 | 161 | $3K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 38 | 38 | $3K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,311 | 1,281 | $3K |
| 90686 | 160 | 160 | $3K | |
| 88360 | 53 | 52 | $3K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 399 | 398 | $3K |
| 82677 | 277 | 269 | $3K | |
| 83615 | 1,160 | 947 | $3K | |
| 88342 | 107 | 106 | $3K | |
| 83605 | 6,946 | 6,626 | $3K | |
| J7050 | Infusion, normal saline solution, 250 cc | 954 | 874 | $3K |
| 84484 | 7,252 | 6,779 | $3K | |
| 76881 | 30 | 25 | $3K | |
| G0009 | Administration of pneumococcal vaccine | 212 | 211 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,126 | 1,089 | $3K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 25 | 24 | $3K |
| 58300 | 15 | 14 | $3K | |
| 86880 | 220 | 196 | $2K | |
| 73080 | 120 | 114 | $2K | |
| 86870 | 99 | 85 | $2K | |
| 87581 | 195 | 194 | $2K | |
| 87486 | 195 | 194 | $2K | |
| 73560 | 88 | 82 | $2K | |
| 83735 | 5,698 | 5,480 | $2K | |
| 81002 | 1,527 | 1,246 | $2K | |
| 82947 | 6,801 | 6,507 | $2K | |
| 84295 | 6,798 | 6,509 | $2K | |
| 90682 | 41 | 41 | $2K | |
| 82435 | 6,788 | 6,499 | $2K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 15 | 13 | $2K |
| 82950 | 717 | 716 | $2K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 13 | 12 | $2K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 26 | 26 | $2K |
| 88313 | 38 | 38 | $2K | |
| 87186 | 1,502 | 1,469 | $2K | |
| 82105 | 344 | 337 | $2K | |
| 73200 | 12 | 12 | $2K | |
| 84550 | 605 | 509 | $2K | |
| 82570 | 618 | 567 | $2K | |
| 86336 | 389 | 316 | $2K | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 14 | 14 | $2K |
| 88300 | 246 | 239 | $1K | |
| 84704 | 213 | 204 | $1K | |
| 84156 | 706 | 625 | $1K | |
| 82607 | 247 | 246 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 14 | 14 | $1K |
| 72050 | 25 | 25 | $1K | |
| 90649 | 15 | 15 | $1K | |
| 87077 | 888 | 867 | $1K | |
| 82728 | 322 | 315 | $1K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 13 | 13 | $1K |
| 84439 | 308 | 305 | $1K | |
| 72082 | 14 | 13 | $1K | |
| 87205 | 858 | 759 | $1K | |
| 99152 | 529 | 513 | $1K | |
| 86140 | 1,392 | 1,357 | $1K | |
| 84100 | 2,611 | 2,537 | $1K | |
| 97165 | 12 | 12 | $971.11 | |
| D0210 | Intraoral - complete series of radiographic images | 50 | 49 | $969.10 |
| 73090 | 89 | 83 | $771.01 | |
| 85379 | 1,897 | 1,872 | $762.64 | |
| 81329 | 13 | 13 | $739.80 | |
| 87070 | 671 | 620 | $738.05 | |
| 81243 | 27 | 27 | $729.38 | |
| 73521 | 30 | 27 | $709.23 | |
| 97802 | 66 | 64 | $675.35 | |
| 86706 | 118 | 117 | $664.60 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 731 | 689 | $662.16 |
| 87040 | 1,581 | 1,527 | $626.43 | |
| 73620 | 41 | 38 | $615.36 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 553 | 551 | $610.69 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 468 | 421 | $497.65 |
| 84132 | 6,962 | 6,663 | $455.80 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 28 | 26 | $445.43 |
| 85652 | 1,173 | 1,145 | $437.20 | |
| J2060 | Injection, lorazepam, 2 mg | 214 | 193 | $430.52 |
| 73522 | 15 | 15 | $413.40 | |
| 82550 | 1,020 | 986 | $386.46 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 363 | 363 | $347.59 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 66 | 63 | $313.41 |
| 95117 | 20 | 12 | $286.44 | |
| C9113 | Injection, pantoprazole sodium, per vial | 97 | 96 | $277.37 |
| 73140 | 27 | 26 | $253.79 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 124 | 82 | $250.45 |
| 93321 | 20 | 15 | $234.08 | |
| 85384 | 60 | 52 | $231.58 | |
| 84145 | 257 | 248 | $230.60 | |
| 85014 | 6,871 | 6,578 | $228.44 | |
| 72170 | 51 | 50 | $222.26 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 37 | 36 | $188.44 |
| 71100 | 12 | 12 | $181.82 | |
| 74019 | 26 | 26 | $176.17 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 102 | 102 | $162.52 |
| 82746 | 29 | 29 | $154.90 | |
| 82043 | 28 | 28 | $112.99 | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 20 | 12 | $98.20 |
| 83550 | 77 | 76 | $98.14 | |
| 85018 | 5,908 | 5,661 | $89.35 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 43 | 43 | $87.93 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 90 | 90 | $84.14 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 12 | 12 | $80.16 |
| 80076 | 14 | 14 | $65.20 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 13 | 13 | $63.50 |
| 87081 | 111 | 111 | $59.97 | |
| 84157 | 70 | 51 | $55.99 | |
| 83540 | 44 | 43 | $55.33 | |
| 82945 | 69 | 50 | $55.01 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 111 | 111 | $45.79 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 26 | 25 | $45.13 |
| 89051 | 111 | 83 | $36.70 | |
| A0888 | Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility) | 715 | 676 | $36.22 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 12 | 12 | $32.46 |
| 84480 | 24 | 24 | $25.64 | |
| 99153 | Mod sedat endo service >5yrs | 59 | 54 | $25.33 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 15 | 15 | $22.01 |
| 82365 | 26 | 24 | $21.61 | |
| 86592 | 14 | 13 | $19.62 | |
| 84436 | 38 | 38 | $11.40 | |
| 82553 | 12 | 12 | $0.00 | |
| 87625 | 27 | 27 | $0.00 | |
| 99429 | 55 | 39 | $0.00 | |
| 99080 | 1,956 | 368 | $0.00 | |
| 82010 | 26 | 24 | $0.00 |